Kerendia (finerenone)

pCPA File Number: 23512

Negotiation Status:

Under consideration for negotiation

Indication(s):

As an adjunct to standard of care in adults with heart failure with left ventricular ejection fraction (LVEF) ≥40% to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visits.

Sponsor/Manufacturer:

Bayer Inc.

CDA-AMC Project Number:

SR0893-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable